Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study.

World journal of gastroenterology - 21 Dec 2009

Gramenzi Annagiulia, Cursaro Carmela, Margotti Marzia, Balsano Clara, Spaziani Alessandra, Anticoli Simona, Loggi Elisabetta, Salerno Maddalena, Galli Silvia, Furlini Giuliano, Bernardi Mauro, Andreone Pietro

Abstract excerpt

AIM: To evaluate the safety of adding ketoprofen to pegylated-interferon (PEG-IFN) with or without ribavirin and the effect on viral kinetics, STAT1 activity and expression of 2'-5'-oligoadenylate synthetase (2'-5'OAS) in genotype 1 chronic hepatitis C in a phase II study. METHODS: Forty-five patients were studied: fifteen were randomized to PEG-IFN plus ribavirin (PR), 16 to PEG-IFN plus ketoprofen and 14 to PR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 2',5'-Oligoadenylate Synthetase
Share to Anti-Inflammatory Agents, Non-Steroidal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Pilot Projects

Share to Polyethylene Glycols

Share to Ribavirin

Share to STAT1 Transcription Factor

Source

Open in PubMed Open full text

Identifiers

PMID: 20014458
DOI: 10.3748/wjg.15.5946
PMCID: PMC2795181

Genes

STAT1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study.PMID 20014458Read ↗

Interferon alfa-2b alone or in combination with ketoprofen as treatment for interferon-naive chronic hepatitis C patients.Semantic proximity Read ↗

Ribavirin improves early responses to peginterferon through improved interferon signaling.Semantic proximity Read ↗

Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activationSemantic proximity Read ↗

S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders.Semantic proximity Read ↗

Safety and pharmacodynamics of intranasal administration of recombinant human interferon alfa-2b as a potential prophylactic for SARS-CoV-2 infection in an at-risk group: a phase I-II clinical trial, open, uncontrolled, in a single-arm (OLIVO Study)Semantic proximity Read ↗

IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18Semantic proximity Read ↗

Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection.Semantic proximity Read ↗

Effect of interferon treatment on serum 2',5'-oligoadenylate synthetase levels in hepatitis C-infected patients.Semantic proximity Read ↗

Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.